Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120078) titled 'A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Effectiveness and Safety of TQC3403 versus Anoro(R) in Patients with Chronic Obstructive Pulmonary Disease' on March 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shenzhen People's Hospital
Condition:
Chronic obstructive pulmonary disease
Intervention:
Experimental group:Umeclidinium Bromide and Vilanterol Trifenatate Powder for Inhalation from Jiangsu Chia Tai Tianqing Pharmaceutical Group Co., Ltd, once daily via oral inhalation.
Recruitment Status: Not Recruiting
Phase: N/A
Date of...